Timing and outcomes of second-line therapy in the era of daratumumab-based frontline therapy in AL amyloidosis.
作者信息
Bazarbachi Abdul-Hamid, Bhutani Divaya, Radhakrishnan Jai, Mapara Markus, Maurer Mathew S, Lentzsch Suzanne, Chakraborty Rajshekhar
机构信息
Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
Division of Nephrology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, New York, USA.
出版信息
Am J Hematol. 2024 Nov;99(11):2225-2228. doi: 10.1002/ajh.27450. Epub 2024 Aug 3.
PMID:39096115
Abstract
摘要
Zotero 插件